SEOM clinical guidelines for the systemic treatment of early breast cancer 2013

Clin Transl Oncol. 2013 Dec;15(12):1011-7. doi: 10.1007/s12094-013-1084-3. Epub 2013 Aug 27.

Abstract

The purpose of this article is to update our previous work on the treatment and follow-up in early breast cancer. In this new version we have classified a treatment by immunohistochemistry subtypes of breast cancer. Latest advances in the management of this disease have been compiled, either in the adjuvant and neoadjuvant setting or chemotherapy and hormonal treatment. This review is presented in an easy way for oncologist, fellows and for other specialties.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant / standards
  • Female
  • Genes, erbB-2
  • Humans
  • Monitoring, Physiologic / standards
  • Neoadjuvant Therapy / standards
  • Neoplasm Staging

Substances

  • Antineoplastic Agents, Hormonal